IGHE and anaphylaxis: In our study, Infants with any symptoms suggestive of CMA (except for clear immediate IgE reactions as anaphylaxis, urticaria and angioedema) were included, regardless of initial CoMiSS at presentation (T0) and including infants with both IgE positive and negative test results.